Actinium Pharmaceuticals, Inc. (ATNM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

31.20M
Year ended 2025-12-31
+8.9%
3-year compound annual growth
2021-12-31: 20.57M2022-12-31: 24.14M2023-12-31: 26.60M2024-12-31: 30.07M2025-12-31: 31.20M31.20M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3131.20M+3.7%2026-03-30, From 2025-01-01
2024-12-3130.07M+13.0%2026-03-30, From 2024-01-01
2023-12-3126.60M+10.2%2025-03-31, From 2023-01-01
2022-12-3124.14M+17.4%2024-03-29, From 2022-01-01
2021-12-3120.57Mn/a2023-03-31, From 2021-01-01